Functional Promoter-1271G>C Variant of HSPB1 Predicts Lung Cancer Risk and Survival

被引:33
|
作者
Guo, Huan
Bai, Yun
Xu, Ping
Hu, Zhibin
Liu, Li
Wang, Fang
Jin, Guangfu
Wang, Feng
Deng, Qifei
Tu, Yixiao
Feng, Maohui
Lu, Daru
Shen, Hongbing
Wu, Tangchun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Occupat Med, Wuhan 430030, Peoples R China
关键词
HEAT-SHOCK PROTEINS; PERIPHERAL-BLOOD LYMPHOCYTES; DNA-DAMAGE; MEDIATED APOPTOSIS; CYTOCHROME-C; HSP27; CELLS; RESISTANCE; INHIBITION; STRESS;
D O I
10.1200/JCO.2009.24.4954
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Heat-shock protein 27 (Hsp27), encoded by HSPB1, plays crucial roles in tumorigenesis and cell survival and is reported to be an independent prognosis marker for cancer. We hypothesized that genetic variants of the HSPB1 gene may be associated with lung cancer susceptibility and survival. Patients and Methods We first resequenced the full-length HSPB1 gene and then genotyped three selected tag single nucleotide polymorphisms (SNPs) in 1,152 paired Chinese lung cancer patient cases and controls. Another 500 paired patient cases and controls were used for replication. We also evaluated the roles of these tagSNPs in the overall survival of 248 patients with advanced non small-cell lung cancer (NSCLC), and validated the results in another 335 patients with advanced NSCLC. The genotype-phenotype correlation was assessed in 309 workers with occupational exposure to polycyclic-aromatic hydrocarbons (PAHs) as well as by luciferase reporter assay and Western blotting analysis. Results The -1271C allele was associated with a significantly increased lung cancer risk in the two independent patient case control studies (P <.05 for both), but it conferred a favorable survival for patients with advanced NSCLC in two independent cohorts (adjusted hazard ratio, 0.66 and 0.75, respectively). The occupational PAH-exposed workers carrying the 1271C allele showed higher DNA damage levels than those with the 1271G allele (P =.027). Furthermore, the 1271C allele significantly decreased luciferase activity in four cell lines and resulted in lower Hsp27 expression levels in normal lung tissues when compared with 1271G allele (P <.05). Conclusion The functional HSPB1 promoter 1271G>C variant may affect lung cancer susceptibility and survival by modulating endogenous Hsp27 synthesis levels.
引用
收藏
页码:1928 / 1935
页数:8
相关论文
共 16 条
  • [1] Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer
    Pang, Qingsong
    Wei, Qingyi
    Xu, Ting
    Yuan, Xianglin
    Lopez Guerra, Jose Luis
    Levy, Lawrence B.
    Liu, Zhensheng
    Gomez, Daniel R.
    Zhuang, Yan
    Wang, Li-E
    Mohan, Radhe
    Komaki, Ritsuko
    Liao, Zhongxing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1332 - 1339
  • [2] Resistin-420C&gt;G promoter variant and colorectal cancer risk
    Mahmoudi, Touraj
    Karimi, Khatoon
    Arkani, Maral
    Farahani, Hamid
    Vahedi, Mohsen
    Dabiri, Reza
    Nobakht, Hossein
    Asadi, Asadollah
    Mirakhorli, Mojgan
    Arshi, Benafsheh
    Derakhshan, Arash
    Zali, Mohammad Reza
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (03) : E233 - E238
  • [3] Late onset dHMN II caused by c.404C&gt;G mutation in HSPB1 gene
    Oberstadt, Moritz
    Mitter, Diana
    Classen, Joseph
    Baum, Petra
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (02) : 111 - 113
  • [4] Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy
    Lopez Guerra, Jose Luis
    Wei, Qingyi
    Yuan, Xianglin
    Gomez, Daniel
    Liu, Zhensheng
    Zhuang, Yan
    Yin, Ming
    Li, Minghuan
    Wang, Li-E
    Cox, James D.
    Liao, Zhongxing
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) : 271 - 277
  • [5] HSPB1 polymorphisms might be associated with radiation-induced damage risk in lung cancer patients treated with radiotherapy
    Li, Xiaofeng
    Xu, Sheng
    Cheng, Yu
    Shu, Jun
    TUMOR BIOLOGY, 2016, 37 (05) : 5743 - 5749
  • [6] HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients After Radio(chemo)therapy for Non-Small Cell Lung Cancer
    Xu, Ting
    Wei, Qingyi
    Lopez Guerra, Jose Luis
    Wang, Li-E
    Liu, Zhensheng
    Gomez, Daniel
    O'Reilly, Michael
    Lin, Steven Hsesheng
    Zhuang, Yan
    Levy, Lawrence B.
    Mohan, Radhe
    Zhou, Honghao
    Liao, Zhongxing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (02): : E229 - E235
  • [7] A functional variant in miR-155 regulation region contributes to lung cancer risk and survival
    Xie, Kaipeng
    Ma, Hongxia
    Liang, Cheng
    Wang, Cheng
    Qin, Na
    Shen, Wei
    Gu, Yayun
    Yan, Caiwang
    Zhang, Kai
    Dai, Ningbin
    Zhu, Meng
    Wu, Shuangshuang
    Wang, Hui
    Dai, Juncheng
    Jin, Guangfu
    Shen, Hongbing
    Hu, Zhibin
    ONCOTARGET, 2015, 6 (40) : 42781 - 42792
  • [8] Association of Interleukin-18 Gene Promoter-607 C&gt;A and-137G&gt;C Polymorphisms with Cancer Risk: A Meta-Analysis of 26 Studies
    Yang, Xin
    Qiu, Man-Tang
    Hu, Jing-Wen
    Jiang, Feng
    Li, Ming
    Wang, Jie
    Zhang, Qin
    Yin, Rong
    Xu, Lin
    PLOS ONE, 2013, 8 (09):
  • [9] Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study
    Chen, Jiawei
    Cui, Xinhai
    Zhou, Hai
    Qin, Chao
    Cao, Qiang
    Ju, Xiaobing
    Li, Pu
    Cai, Hongzhou
    Zhu, Jian
    Meng, Xiaoxin
    Wang, Meilin
    Zhang, Zhengdong
    Shao, Pengfei
    Li, Jie
    Yin, Changjun
    BMC CANCER, 2013, 13 : 1 - 7
  • [10] Combined analysis of EGF+61G&gt;A and TGFB1+869T&gt;C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility
    Teixeira, A. L.
    Ribeiro, R.
    Morais, A.
    Lobo, F.
    Fraga, A.
    Pina, F.
    Calais-da-Silva, F. M.
    Calais-da-Silva, F. E.
    Medeiros, R.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (05) : 341 - 346